JW Pharmaceutical Corp (001065) — Free Cash Flow Generation Index
JW Pharmaceutical Corp (001065) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of ₩37.12 Billion represents 1% of operating cash flow (₩46.92 Billion). See JW Pharmaceutical Corp (001065) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
JW Pharmaceutical Corp Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for JW Pharmaceutical Corp across 10 annual periods. Explore JW Pharmaceutical Corp (001065) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for JW Pharmaceutical Corp (2014–2024)
Year-by-year Free Cash Flow Generation Index for JW Pharmaceutical Corp. For the full company profile including market capitalisation, see JW Pharmaceutical Corp stock valuation.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | ₩51.25 Billion | ₩79.39 Billion | ₩28.14 Billion | ▲ +21.1% |
| 2023 | 0.53x | ₩46.45 Billion | ₩87.16 Billion | ₩40.71 Billion | ▼ -31.9% |
| 2022 | 0.78x | ₩44.41 Billion | ₩56.76 Billion | ₩9.92 Billion | ▲ +171.5% |
| 2021 | 0.29x | ₩5.22 Billion | ₩18.12 Billion | ₩7.47 Billion | ▼ -62.2% |
| 2020 | 0.76x | ₩48.02 Billion | ₩63.05 Billion | ₩12.39 Billion | ▼ -0.3% |
| 2019 | 0.76x | ₩42.43 Billion | ₩55.53 Billion | ₩9.28 Billion | ▼ -9.0% |
| 2018 | 0.84x | ₩43.76 Billion | ₩52.11 Billion | ₩8.64 Billion | ▲ +24.9% |
| 2017 | 0.67x | ₩22.50 Billion | ₩33.45 Billion | ₩7.50 Billion | ▼ -73.0% |
| 2016 | 2.49x | ₩16.76 Billion | ₩6.74 Billion | ₩10.02 Billion | ▲ +27.4% |
| 2014 | 1.95x | ₩14.21 Billion | ₩7.28 Billion | ₩6.93 Billion | — |